Erick Herrscher has been named director of the Hyundai Cancer Institute at CHOC Children’s. Working in partnership with hospital and physician leaders, Herrscher will be responsible for advancing CHOC as a leading destination for cutting-edge cancer care for children and young adults.
“The Hyundai Cancer Institute is consistently ranked a top pediatric cancer program by U.S. News & World Report. It’s a privilege to join such a renowned team of experts who are dedicated to finding new cures and treatments, and strengthening survivorship,” Herrscher said. “I am excited to join this mighty brigade in supporting CHOC’s mission to nurture, advance and protect the health and well-being of children.”
In his role, Herrscher will also support the recruitment of new physicians and oversee related program development to benefit CHOC’s patients with cancer as well as their families.
Herrscher joins CHOC from the Meyer Cancer Center at Weill Cornell Medicine in partnership with NewYork-Presbyterian Hospital. There, he most recently served as director of administration and finance, which included responsibilities across strategic planning and evaluation, disease management teams and related clinical research, and community outreach. He has a special interest in cancer care and research and has served in a variety of cancer-focused roles at Weill Cornell Medicine, NYU Langone Medical Center, and the Huntsman Cancer Institute at the University of Utah.
After earning a bachelor’s degree from the University of Utah, Herrscher earned master’s degrees in business administration as well as healthcare leadership at Cornell University and Weill Cornell Medicine, respectively.
